Share-based Payment Arrangement, Expense of Inari Medical, Inc. from 31 Dec 2018 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Inari Medical, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2018 to 30 Sep 2024.
  • Inari Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $12,951,000, a 32% increase year-over-year.
  • Inari Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $48,661,000, a 28% increase year-over-year.
  • Inari Medical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40,337,000, a 41% increase from 2022.
  • Inari Medical, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28,671,000, a 13% increase from 2021.
  • Inari Medical, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $25,448,000, a 622% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Inari Medical, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $48,661,000 $12,951,000 +$3,107,000 +32% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2024 2024 Q3
Q2 2024 $45,554,000 $13,039,000 +$2,686,000 +26% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2024 2024 Q2
Q1 2024 $42,868,000 $12,870,000 +$2,531,000 +24% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2024 2024 Q1
Q4 2023 $40,337,000 $9,801,000 +$2,205,000 +29% 01 Oct 2023 31 Dec 2023 10-K 29 Feb 2024 2023 FY
Q3 2023 $38,132,000 $9,844,000 +$2,488,000 +34% 01 Jul 2023 30 Sep 2023 10-Q 28 Oct 2024 2024 Q3
Q2 2023 $35,644,000 $10,353,000 +$3,189,000 +45% 01 Apr 2023 30 Jun 2023 10-Q 30 Jul 2024 2024 Q2
Q1 2023 $32,455,000 $10,339,000 +$3,784,000 +58% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024 2024 Q1
Q4 2022 $28,671,000 $7,596,000 +$3,087,000 +68% 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $25,584,000 $7,356,000 -$5,143,000 -41% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 $30,727,000 $7,164,000 +$2,560,000 +56% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $28,167,000 $6,555,000 +$2,719,000 +71% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 $25,448,000 $4,509,000 +$2,943,000 +188% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $22,505,000 $12,499,000 +$11,540,000 +1203% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $10,965,000 $4,604,000 +$4,099,000 +812% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $6,866,000 $3,836,000 +$3,342,000 +677% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $3,524,000 $1,566,000 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q3 2020 $959,000 +$819,000 +585% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $505,000 +$406,000 +410% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 $494,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 $140,000 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $99,000 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2

Inari Medical, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $40,337,000 +$11,666,000 +41% 01 Jan 2023 31 Dec 2023 10-K 29 Feb 2024 2023 FY
2022 $28,671,000 +$3,223,000 +13% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 $25,448,000 +$21,924,000 +622% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $3,524,000 +$3,019,000 +598% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $505,000 +$257,000 +104% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $248,000 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.